HPA039159
antibody from Atlas Antibodies
Targeting: CNGB1
CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA039159 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA039159, RRID:AB_10795579
- Product name
- Anti-CNGB1
- Antibody type
- Polyclonal
- Description
- Affinity purified using the PrEST antigen as affinity ligand
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Antigen sequence
LRSNNKPKEEKSVLILPPRAGTPKLFNAALAMTGK
MGGKGAKGGKLAHLRARLKELAALEAAAKQQELVE
QAKSSQDVKGEEGSAAPDQHTHPKE- Isotype
- IgG
- Vial size
- 100 µl
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Submitted references Redefining the role of Ca2+-permeable channels in photoreceptor degeneration using diltiazem
In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa
Patients and animal models of CNGβ1-deficient retinitis pigmentosa support gene augmentation approach
Das S, Popp V, Power M, Groeneveld K, Yan J, Melle C, Rogerson L, Achury M, Schwede F, Strasser T, Euler T, Paquet-Durand F, Nache V
Cell Death & Disease 2022;13(1)
Cell Death & Disease 2022;13(1)
In Vivo Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Cngb1 Knockout Mouse Model of Retinitis Pigmentosa
Wagner J, Zobel L, Gerhardt M, O'Riordan C, Frederick A, Petersen-Jones S, Biel M, Michalakis S
Human Gene Therapy 2021;32(19-20):1158-1170
Human Gene Therapy 2021;32(19-20):1158-1170
Patients and animal models of CNGβ1-deficient retinitis pigmentosa support gene augmentation approach
Petersen-Jones S, Occelli L, Winkler P, Lee W, Sparrow J, Tsukikawa M, Boye S, Chiodo V, Capasso J, Becirovic E, Schön C, Seeliger M, Levin A, Michalakis S, Hauswirth W, Tsang S
Journal of Clinical Investigation 2017;128(1):190-206
Journal of Clinical Investigation 2017;128(1):190-206
No comments: Submit comment
No validations: Submit validation data